Sfoglia per Autore
HIGH RESOLUTION MRI TO ASSESS AXONAL DAMAGE IN NEUROPATHY MODELS
2025 Bontempi, P; Mastropietro, A; Rizzo, G; Taccogna, M; Napolitano, A; Gerevini, S; Kraus, M; Di Girolamo, S; Cavaletti, G; Tamburin, S; Alberti, P
Chemotherapy-Induced Peripheral Neurotoxicity (CIPN)
2025 Cavaletti, G; Marmiroli, P
ITF6475, a New Histone Deacetylase 6 Inhibitor, Prevents Painful Neuropathy Induced by Paclitaxel
2025 Cavaletti, G; Canta, A; Chiorazzi, A; Pozzi, E; Carozzi, V; Meregalli, C; Alberti, P; Marmiroli, P; Scuteri, A; Crippa, L; Fermi, S; Segmani, I; Vergani, B; Steinkühler, C; Licandro, S
Paclitaxel Alters Drg SGCs in Animals with Peripheral Neuropathy
2025 Carozzi, V; Ballarini, E; Rodriguez Menendez, V; Alberti, P; Canta, A; Chiorazzi, A; Meregalli, C; Cherchi, L; D'Aprile, C; Cavaletti, G; Pozzi, E
Bioresponsive Hyaluronic Acid-Based Hydrogel Inhibits Matrix Metalloproteinase-2 in Glioblastoma Microenvironment
2025 Barbugian, F; Salerno, D; Ballarini, E; Crippa, L; Francesconi, O; Mantegazza, F; Cavaletti, G; Roelens, S; Leone, G; Pepi, S; Talarico, L; Magnani, A; Nativi, C; Russo, L
Sodium channel modulation as a therapeutic strategy for chemotherapy-induced peripheral neurotoxicity
2025 Di Girolamo, S; Terribile, G; Alberti, P; Cavaletti, G
Histone Deacetylase 6 Inhibitors: Mitigators Of Chemotherapy Induced Peripheral Neuropathy Via The NMNAT2/SARM1 Pathway Modulation
2025 Fermi, S; Malacrida, A; Molteni, L; Miloso, M; Cavaletti, G; Nicolini, G
Eculizumab as a Disease-Modifying Therapy in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): A Case Report
2025 Schilke, E; Cereda, D; Fusco, M; Stanzani, L; Marzorati, L; Ripolone, M; Bertolasi, L; Frigo, M; Molteni, F; Farina, N; Ferrarese, C; Cavaletti, G; Balducci, C
Molecular Characterization of Oxaliplatin-Induced Peripheral Neurotoxicity: The Complex Spectrum of Painful Manifestations
2025 Pozzi, E; Serra, M; Boi, M; Canta, A; Chiorazzi, A; Capelli, C; Invernizzi, C; Ballarini, E; Rodriguez‐menendez, V; Kraus, M; Quartu, M; Cavaletti, G; Alberti, P
MicroRNA-142-3p shuttling in extracellular vesicles marks regulatory T cell dysfunction in multiple sclerosis
2025 De Rosa, G; Russo, C; Garavelli, S; Di Silvestre, D; Spatocco, I; Mele, G; Rocca, C; Colamatteo, A; Carbone, F; Fusco, C; Passaro, F; Carpi, D; Tagliabue, E; Prattichizzo, F; Brambilla, F; Mauri, P; Hoxha, M; Bollati, V; Giusti, I; Dolo, V; D'Antona, P; Campomenosi, P; Mangolini, V; Radeghieri, A; Bergese, P; Morabito, I; Mandelli, A; Finardi, A; Beretta, F; Schilke, E; Cavaletti, G; Dolcetti, E; Buttari, F; Abbadessa, G; Bonavita, S; Lus, G; Signoriello, E; Lanzillo, R; Morra, V; Mottola, M; Zuccarelli, B; Uccelli, A; Salvetti, M; Centonze, D; Furlan, R; Matarese, G; Procaccini, C; De Candia, P
SARM1 modulation by HDAC6 inhibition as a neuroprotective strategy in chemotherapy-induced peripheral neuropathy
2025 Fermi, S; Malacrida, A; Molteni, L; Miloso, M; Cavaletti, G; Nicolini, G
High-Resolution MRI for Peripheral Nervous System Imaging: Volumetric Rendering in Rodent Models
2025 Kraus, M; Mastropietro, A; Rizzo, G; Bontempi, P; Tamburin, S; Cavaletti, G; Alberti, P
Analysis of an innovative fluid biomarker panel for early prediction of progression independent of relapse activity in multiple sclerosis
2025 Schilke, E; Frigo, M; Fusco, M; Cappellani, A; Cereda, D; Zoia, C; Cavaletti, G
Paclitaxel activates SOCE/ICRAC in dorsal root ganglion neurons: implications for paclitaxel-induced peripheral neuropathy
2025 Delconti, M; Ravasenga, T; Dionisi, M; Romanazzi, T; Chiazza, F; Giatti, S; Lim, D; Genazzani, A; Riva, B; Meregalli, C; Cavaletti, G; Distasi, C
Angiogenesis-Related New Mechanisms for Chemotherapy-Induced Painful Peripheral Neuropathy in the Rat
2024 Carozzi, V; Rodriguez-Menendez, V; Pozzi, E; Canta, A; Chiorazzi, A; Ballarini, E; Alberti, P; Meregalli, C; Cordani, N; Donà, E; Ramazzotti, D; Bravin, A; Tromba, G; Cavaletti, G; Giuliano Zippo, A
Oxaliplatin-induced peripheral neurotoxicity: molecular insights
2024 Alberti, P; Pozzi, E; Serra, M; Trucas, M; Boi, M; Capelli, C; Invernizzi, C; Chiorazzi, A; Ballarini, E; Rodriguez-Menendez, V; Quartu, M; Cavaletti, G
Effect of age on metabolomic changes in a model of paclitaxel‐induced peripheral neurotoxicity
2024 Bonomo, R; Canta, A; Chiorazzi, A; Carozzi, V; Meregalli, C; Pozzi, E; Alberti, P; Frampas, C; Van der Veen, D; Marmiroli, P; Skene, D; Cavaletti, G
Current use of fluid biomarkers as outcome measures in Multiple Sclerosis (MS): a review of ongoing pharmacological clinical trials
2024 Schilke, E; Remoli, G; Funelli, E; Galimberti, M; Fusco, M; Cereda, D; Balducci, C; Frigo, M; Cavaletti, G
Morphofunctional characterisation of axonal damage in different rat models of chemotherapy-induced peripheral neurotoxicity: the role of nerve excitability testing
2024 Chiorazzi, A; Canta, A; Carozzi, V; Meregalli, C; Pozzi, E; Ballarini, E; Rodriguez-Menendez, V; Marmiroli, P; Cavaletti, G; Alberti, P
Translation of paclitaxel-induced peripheral neurotoxicity from mice to patients: the importance of model selection
2024 Cavaletti, G; Alberti, P; Canta, A; Carozzi, V; Cherchi, L; Chiorazzi, A; Crippa, L; Marmiroli, P; Meregalli, C; Pozzi, E; Rodriguez-Menendez, V; Steinkühler, C; Licandro, S
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile